EE+ POEM Archive
Apixaban is noninferior to dalteparin for venous thromboembolism associated with cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Apixaban Is Noninferior to Dalteparin for Venous Thromboembolism Associated With Cancer." EE+ POEM Archive, John Wiley & Sons, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315130/all/Apixaban_is_noninferior_to_dalteparin_for_venous_thromboembolism_associated_with_cancer.
Apixaban is noninferior to dalteparin for venous thromboembolism associated with cancer. In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2019. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315130/all/Apixaban_is_noninferior_to_dalteparin_for_venous_thromboembolism_associated_with_cancer. Accessed September 18, 2024.
Apixaban is noninferior to dalteparin for venous thromboembolism associated with cancer. (2019). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315130/all/Apixaban_is_noninferior_to_dalteparin_for_venous_thromboembolism_associated_with_cancer
Apixaban Is Noninferior to Dalteparin for Venous Thromboembolism Associated With Cancer [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2019. [cited 2024 September 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315130/all/Apixaban_is_noninferior_to_dalteparin_for_venous_thromboembolism_associated_with_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Apixaban is noninferior to dalteparin for venous thromboembolism associated with cancer
ID - 1315130
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1315130/all/Apixaban_is_noninferior_to_dalteparin_for_venous_thromboembolism_associated_with_cancer
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
